GL Pharm Tech Corp. (KOSDAQ: 204840)

GL Pharm Tech Balance Sheet

Financials in millions KRW. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Jun 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	6,316	4,136	4,639	6,189	9,490	324.13
Short-Term Investments	-	-	-	-	-	30
Trading Asset Securities	3,141	-	-	-	-	304.27
Cash & Short-Term Investments	9,457	4,136	4,639	6,189	9,490	658.41
Cash Growth	56.08%	-10.86%	-25.03%	-34.78%	1341.31%	-77.55%
Accounts Receivable	4,818	5,618	5,514	3,480	3,522	3,360
Other Receivables	-	173.99	156.25	180.71	113.61	187.02
Receivables	4,818	5,792	5,671	3,660	3,636	3,547
Inventory	7,006	6,640	5,508	3,387	2,742	2,100
Prepaid Expenses	-	2.14	-	0.2	0.4	29.18
Other Current Assets	238.5	49.21	372.14	32.77	101.56	13.17
Total Current Assets	21,518	16,619	16,190	13,270	15,970	6,348
Property, Plant & Equipment	18,477	18,864	19,850	15,465	15,636	15,733
Long-Term Investments	3,175	2,992	3,020	1,024	525.86	736.1
Goodwill	-	-	-	-	278.13	278.13
Other Intangible Assets	1,103	819.28	1,043	1,253	1,457	1,699
Long-Term Deferred Charges	-	208.33	435.8	663.27	890.74	1,150
Other Long-Term Assets	93.54	189.61	144.75	121.3	100.65	401.76
Total Assets	44,367	39,868	40,854	31,895	34,945	26,547
Accounts Payable	2,518	2,564	3,104	623.4	895.04	1,030
Accrued Expenses	-	1,017	1,707	645	651.27	394.83
Short-Term Debt	3,100	4,380	2,030	1,980	3,929	9,961
Current Portion of Long-Term Debt	6,000	2,000	4,350	249.96	249.96	1,950
Current Portion of Leases	91.08	77.92	71.68	88.82	71.15	48.41
Current Unearned Revenue	-	335	50	-	225	-
Other Current Liabilities	2,799	1,945	1,790	1,278	1,640	2,776
Total Current Liabilities	14,509	12,319	13,104	4,865	7,662	16,159
Long-Term Debt	6,497	11,247	7,400	5,450	8,652	3,669
Long-Term Leases	141.66	79.94	57.92	109.94	114.91	66.67
Long-Term Unearned Revenue	-	943.07	1,313	1,032	1,031	1,274
Long-Term Deferred Tax Liabilities	1,984	2,005	2,200	2,243	2,818	2,327
Other Long-Term Liabilities	1,168	0	0	0	0	121.58
Total Liabilities	24,718	27,586	24,764	14,415	20,630	24,185
Common Stock	7,670	6,235	6,210	6,185	4,721	3,578
Additional Paid-In Capital	34,007	25,615	25,558	25,795	19,982	6,665
Retained Earnings	-22,050	-19,251	-15,502	-15,313	-11,193	-7,992
Treasury Stock	-0.11	-0.11	-0.11	-0.11	-0.11	-0.11
Comprensive Income & Other	22.2	-317.23	-175.7	182.01	303.02	110.25
Total Common Equity	19,649	12,282	16,090	16,849	13,813	2,362
Minority Interest	-	-	-	630.18	-	-
Shareholders' Equity	19,649	12,282	16,090	17,480	14,315	2,362
Total Liabilities & Equity	44,367	39,868	40,854	31,895	34,945	26,547
Total Debt	15,830	17,785	13,910	7,879	13,017	15,695
Net Cash (Debt)	-6,374	-13,650	-9,270	-1,690	-3,527	-15,036
Net Cash Per Share	-95.10	-219.33	-149.46	-33.23	-78.39	-420.20
Filing Date Shares Outstanding	76.7	62.35	62.1	61.85	47.21	35.78
Total Common Shares Outstanding	76.7	62.35	62.1	61.85	47.21	35.78
Working Capital	7,009	4,301	3,086	8,404	8,308	-9,812
Book Value Per Share	256.18	196.98	259.09	272.40	292.58	66.00
Tangible Book Value	18,546	11,463	15,047	15,596	12,078	384.34
Tangible Book Value Per Share	241.80	183.84	242.29	252.15	255.83	10.74
Land	-	10,266	10,266	9,491	9,491	9,542
Buildings	-	7,530	7,530	4,417	4,567	4,611
Machinery	-	8,674	8,180	8,130	7,703	6,807
Construction In Progress	-	-	200	254	109.06	-

Source: S&P Capital IQ. Standard template. Financial Sources.